Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Spironolactone can reduce hair growth in women with hirsutism.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Muscles can make their own androgens, which may help muscle growth.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.